Tablet for use in treating huntington's disease and method of making the same

A tablet comprising, as an active ingredient, 2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-[1,2,3]triazolo[4,5-c]pyridazin-6-yl]-5-(2H-1,2,3-triazol-2-yl)phenol (hereinafter Compound 1), or a pharmaceutically acceptable salt thereof, wherein Compound 1 is present in an amount from about 5% to about 30% by weight of the total weight of the tablet, an intragranular excipient, and an extragranular excipient;

• wherein the intragranular excipient comprises microcrystalline cellulose and a diluent;
• wherein the ratio of microcrystalline cellulose to diluent is about 1:1 to about 1:4 and the microcrystalline cellulose is present in an amount of about 15% to about 25% by weight of the total weight of the tablet;
• wherein the disintegrant is present in an amount of about 1% to about 3% of the total weight of the tablet;
• wherein povidone is present in an amount of 1% to about 5% by weight of the total weight of the tablet;
• and, wherein the extragranular excipient comprises an additional amount of the diluent and an additional amount of the disintegrant.